Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes

OBJECTIVE: As gene-based therapies may soon arise for patients with spinocerebellar ataxia (SCA), there is a critical need to identify biomarkers of disease progression with effect sizes greater than clinical scores, enabling trials with smaller sample sizes. METHODS: We enrolled a unique cohort of...

Descripción completa

Detalles Bibliográficos
Autores principales: Adanyeguh, Isaac M., Perlbarg, Vincent, Henry, Pierre-Gilles, Rinaldi, Daisy, Petit, Elodie, Valabregue, Romain, Brice, Alexis, Durr, Alexandra, Mochel, Fanny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005808/
https://www.ncbi.nlm.nih.gov/pubmed/29922574
http://dx.doi.org/10.1016/j.nicl.2018.06.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005808/
https://www.ncbi.nlm.nih.gov/pubmed/29922574
http://dx.doi.org/10.1016/j.nicl.2018.06.011

Ejemplares similares